国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
5期
565-568
,共4页
复方倍他米松注射液%曲安奈德注射液%瘢痕疙瘩
複方倍他米鬆註射液%麯安奈德註射液%瘢痕疙瘩
복방배타미송주사액%곡안내덕주사액%반흔흘탑
Compound betamethasone injection%Triamcinolone acetonide injection%Keloid
目的 观察复方倍他米松注射液与曲安奈德注射液治疗疤痕疙瘩的疗效和不良反应.方法 将212例患者分为A、B两组,A组用复方倍他米松注射液局部注射至瘢痕,4周1次,酌情注射1~5次,B组用曲安奈德注射液局部注射,2周1次,酌情注射1~5次,6月和12月后随访.结果 A组116例(皮损477个),痊愈率82.39%,有效率95.81%,半年复发率9.89%,不良反应的发生率为11.21%.其中女性月经失调发生率5.97%,B组96例(皮损389个),痊愈率75.32%,有效率88.43%,半年复发率13.86%,不良反应的发生率为21.88%,女性月经失调发生率19.64%.结论 局部注射复方倍他米松注射液和曲安奈德注射液治疗搬痕疙瘩均有较好的疗效,且复方倍他米松注射液疗效更佳,对女性患者月经影响较少,但复发率仍较高.
目的 觀察複方倍他米鬆註射液與麯安奈德註射液治療疤痕疙瘩的療效和不良反應.方法 將212例患者分為A、B兩組,A組用複方倍他米鬆註射液跼部註射至瘢痕,4週1次,酌情註射1~5次,B組用麯安奈德註射液跼部註射,2週1次,酌情註射1~5次,6月和12月後隨訪.結果 A組116例(皮損477箇),痊愈率82.39%,有效率95.81%,半年複髮率9.89%,不良反應的髮生率為11.21%.其中女性月經失調髮生率5.97%,B組96例(皮損389箇),痊愈率75.32%,有效率88.43%,半年複髮率13.86%,不良反應的髮生率為21.88%,女性月經失調髮生率19.64%.結論 跼部註射複方倍他米鬆註射液和麯安奈德註射液治療搬痕疙瘩均有較好的療效,且複方倍他米鬆註射液療效更佳,對女性患者月經影響較少,但複髮率仍較高.
목적 관찰복방배타미송주사액여곡안내덕주사액치료파흔흘탑적료효화불량반응.방법 장212례환자분위A、B량조,A조용복방배타미송주사액국부주사지반흔,4주1차,작정주사1~5차,B조용곡안내덕주사액국부주사,2주1차,작정주사1~5차,6월화12월후수방.결과 A조116례(피손477개),전유솔82.39%,유효솔95.81%,반년복발솔9.89%,불량반응적발생솔위11.21%.기중녀성월경실조발생솔5.97%,B조96례(피손389개),전유솔75.32%,유효솔88.43%,반년복발솔13.86%,불량반응적발생솔위21.88%,녀성월경실조발생솔19.64%.결론 국부주사복방배타미송주사액화곡안내덕주사액치료반흔흘탑균유교호적료효,차복방배타미송주사액료효경가,대녀성환자월경영향교소,단복발솔잉교고.
Objective To observe and compare the effect and side-effect of keloid treated by Compound Betamethasone injection and Triamcinolone Acetonide injection. Methods Group A was injected locally with compound Betamethasone to keliod every 4 weeks, totally 1~5 times according the status, Group B was injected locally with Triamcinolone Acetonide to keliod every 2 weeks, totally 1~5 times according the status. All the patients were visited followed 6monthes and 12monthes after treatment. Results Group A involved 116 patients (477 lesions), and the curative rate, effective rate, relapse rate of group A was 82.39%, 95.81%, 9.89% respectively. The side-effect occurred in 11.21% patients (include menstrual irregulation occurred in female was 5.97%). Group B involved 96 patients (389 lesions ), and the curative rate, effective rate, relapse rate was 75.32%, 88.43%, 13.86% respectively. The side-effect rate was 21.88% (include menstrual irregulation occurred in female was 19.64%).Conclusion Both are effective either by Compound Betamethasone or by Triamcinolone Acetonide to treat keloid, while the Compound Betamethasone is better, and has fewer influence on female menses, however the relapse rate is high.